Akm Khairuzzaman
FDA/CDER/OPQ/OPF
Branch Chief (Acting)
Dr. Khairuzzaman is a Branch Chief at FDA’s Office of Office of Pharmaceutical Quality, CDER, where he leads a group of review scientist responsible for assessment of chemistry, manufacturing, controls (CMC) for investigational new drug applications (IND), new drug application (NDA), and abbreviated new drug application (ANDA) seeking approval in US market. Prior joining to FDA as a Fellow in the year of 2008, Dr. Khairuzzaman worked for Barr Pharmaceuticals Inc. (currently owned by TEVA) for seven (7) years as a Scientist and Research Investigator in its research and development group.
<br><br>
Dr. Khairuzzaman has published seven (7) scientific papers in internationally renowned peer review journal, presented eleven (11) abstracts at international science meetings (AAPS and CRS) and was an invited speaker by many institutions notably, the National Institute of Health (NIH) and US universities. Dr. Khairuzzaman has a bachelor degree (B.S.) in Pharmacy. His graduate degrees, M.S. in Industrial Pharmacy and Ph.D. in Pharmaceutics are from Long Island University, New York, USA.
<!--March 2016, jbayne-->
<br><br>
Dr. Khairuzzaman has published seven (7) scientific papers in internationally renowned peer review journal, presented eleven (11) abstracts at international science meetings (AAPS and CRS) and was an invited speaker by many institutions notably, the National Institute of Health (NIH) and US universities. Dr. Khairuzzaman has a bachelor degree (B.S.) in Pharmacy. His graduate degrees, M.S. in Industrial Pharmacy and Ph.D. in Pharmaceutics are from Long Island University, New York, USA.
<!--March 2016, jbayne-->